At 9 months, oerall, those who receied TTA showed greater improement or stability in parameters such as proptosis and diplopia.

• 在术后9个月，接受甲状腺次全切除术+放碘治疗患者在眼球突出、复视等方面较仅行甲状腺次全切除术患者明显改善或稳定。